INSIDER
Judge orders Martin Shkreli to turn over all copies of unreleased Wu-Tang Clan album
Read full article: Judge orders Martin Shkreli to turn over all copies of unreleased Wu-Tang Clan album“Pharma Bro” Martin Shkreli has been ordered to turn over copies of Wu-Tang Clan's unreleased “Once Upon a Time in Shaolin'” album to his lawyers by Friday.
American investor Martin Shkreli accused of copying and sharing one-of-a-kind Wu-Tang Clan album
Read full article: American investor Martin Shkreli accused of copying and sharing one-of-a-kind Wu-Tang Clan albumAmerican investor Martin Shkreli is facing a new lawsuit for allegedly retaining and sharing recordings from a one-of-a-kind Wu-Tang Clan album that he was forced to sell following his 2017 conviction on fraud charges.
Wu-Tang Clan's unreleased 'Once Upon a Time in Shaolin' is headed to an Australia museum
Read full article: Wu-Tang Clan's unreleased 'Once Upon a Time in Shaolin' is headed to an Australia museumThe sole physical copy of Wu-Tang Clan’s unreleased “Once Upon a Time in Shaolin” is headed to Australia’s Museum of Old and New Art.
'Pharma Bro' Shkreli freed from prison for halfway house
Read full article: 'Pharma Bro' Shkreli freed from prison for halfway houseConvicted pharmaceutical executive Martin Shkreli has been freed from prison after serving much of a seven-year prison sentence for lying to hedge fund investors and cheating investors in a drug company.
Shkreli ordered to return $64M, is barred from drug industry
Read full article: Shkreli ordered to return $64M, is barred from drug industryA federal judge has ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life.
'Pharma Bro' firm reaches $40M settlement in gouging case
Read full article: 'Pharma Bro' firm reaches $40M settlement in gouging caseA company once owned by “Pharma Bro” Martin Shkreli will pay up to $40 million to settle allegations that it jacked up the price of a life-saving medication by roughly 4 ,000% after obtaining exclusive rights to the drug.
'Pharma Bro' Shkreli loses 2nd bid for early prison release
Read full article: 'Pharma Bro' Shkreli loses 2nd bid for early prison releaseFILE - In this Aug. 3, 2017, file photo, Martin Shkreli arrives at federal court in New York. Matsumoto noted that Shkreli recently had a two-hour Zoom session with his lawyers, as well as several phone calls up to an hour in length. Prosecutors said that, as of Jan. 6, there were no positive cases in Shkreli’s housing unit. Shkreli, who was ordered to forfeit $7.3 million as part of his sentence, is due to be released from prison in September 2023. He is also known for attacking critics on social media and offering a bounty to anyone who could give him one of Hillary Clinton’s hairs.
'Delusional' Martin Shkreli denied prison release by judge
Read full article: 'Delusional' Martin Shkreli denied prison release by judgeNEW YORK A judge rejected the request of convicted pharmaceutical executive Martin Shkreli to be let out of prison to research a coronavirus treatment, noting that probation officials viewed that claim as the type of delusional self-aggrandizing behavior that led to his conviction. U.S. District Judge Kiyo Matsumoto said in a nine-page ruling Saturday that the man known as the Pharma Bro" failed to demonstrate extraordinary and compelling factors that would require his release under home confinement rules designed to move vulnerable inmates out of institutions during the pandemic. Disappointed but not unexpected, Shkrelis lawyer, Benjamin Brafman, said. A judge ordered Shkreli to forfeit $7.3 million. He is also known for attacking critics on social media and offering a bounty to anyone who could give him one of Hillary Clintons hairs.